FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to experimental oncology, and can be used to stimulate the oncological process by modifying the carcinogenesis of diabetes mellitus. The method for stimulating hematogenous dissemination of carcinoma in the experiment is that in female nonlinear rats at the age of 3.5-4 months diabetes mellitus (DM) is induced by a single intraperitoneal injection of alloxan at a dose of 150 mg/kg of body weight. After 1 week, against the background of a consistently high level of glucose in the blood, the rats are inoculated with Guerin's carcinoma by injecting tumor suspension under the skin of the right scapula in a volume of 0.5 ml and diluting in physiological solution 1:5.
EFFECT: invention can serve as a model for studying the role of diabetes mellitus in the pathogenesis of malignant growth, as well as for finding ways of drug treatment of this pathology; the method is economical and affordable.
1 cl, 4 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR CREATING AN EXPERIMENTAL MODEL OF TUMOR GROWTH IN CONDITIONS OF HYPOTHYROIDISM | 2021 |
|
RU2779358C1 |
| METHOD FOR CREATING EXPERIMENTAL MODEL OF LEWIS CARCINOMA IN CONDITIONS OF HYPERTHYROIDISM | 2023 |
|
RU2824963C1 |
| METHOD FOR ENHANCING THE GROWTH OF B16/F10 MELANOMA VERSUS THE GROWTH OF B16/F10 MELANOMA WITH SELF-GRAFTING AND SLOWING THE GROWTH OF LLC (LEWIS CARCINOMA) VERSUS THE GROWTH OF LLC WITH SELF-GRAFTING IN CASE OF MULTIPLE PRIMARY MALIGNANT TUMORS AGAINST THE BACKGROUND OF PRIMARY IMMUNODEFICIENCY | 2021 |
|
RU2759487C1 |
| A METHOD FOR MODELING THE PRIMARY MULTIPLE GROWTH OF MALIGNANT TUMORS WITH THE SUPPRESSION OF ONE TUMOR BY ANOTHER IN THE CONDITIONS OF PRIMARY IMMUNODEFICIENCY | 2021 |
|
RU2750127C1 |
| METHOD FOR CREATING ORTHOTOPIC ENDOMETRIAL CANCER MODEL | 2024 |
|
RU2818464C1 |
| METHOD OF MODIFYING THE DEVELOPMENT OF ADENOCARCINOMA EXPERIMENTALLY | 2020 |
|
RU2743960C1 |
| METHOD FOR CREATING POLYNEOPLASIA WITH STIMULATION OF TUMOR GROWTH IN CONDITIONS OF PRIMARY IMMUNODEFICIENCY IN EXPERIMENT | 2021 |
|
RU2751930C1 |
| METHOD FOR MODELING OVARIAN CANCER EXPERIMENTALLY IN RATS | 2020 |
|
RU2743219C1 |
| METHOD FOR MURINE MELANOMA LYMPHATIC AND HEMATOGENOUS METASTASIS B SIMULATION FOR NONLINEAR WHITE RATS | 2016 |
|
RU2615908C1 |
| METHOD OF STIMULATING CHRONIC PAIN OF MALIGNANT GROWTH IN LUNG RATS | 2018 |
|
RU2676641C1 |
